Resumen
Aims: The mineralocorticoid receptor (MR) is a ubiquitous nuclear receptor that is increased during obesity. Fibroblast growth factor 21 (FGF-21) is a hepatokine that enhances glucose metabolism by binding and activating fibroblast growth factor receptors in complex with the beta-klotho co-receptor (β-klotho). This study tested the hypothesis that adipocyte MR contributes to the development of glucose intolerance in obesity settings by impairing FGF-21-mediated glucose handling in adipose tissue. Materials and Methods: An adipocyte-specific inducible MR knockout (AdipoMRKO) mouse model was generated to investigate metabolic effects during obesity. Tamoxifen-induced MR deletion was performed in 14-week-old male and female mice after 9 weeks on a high-fat diet (HFD). MR floxed (AdipoMRfl) mice served as control littermates. Body weight, body composition, oral glucose tolerance, insulin tolerance, Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), and adipokines were measured 4 weeks post-treatment. Results: Body weight and composition were not significantly different before or after MR deletion in mice of either sex. In HFD-fed male AdipoMRKO mice, glucose tolerance and HOMA-IR were improved, while insulin-sensitising genes including β-klotho were increased in perigonadal white adipose tissue (gWAT) compared with AdipoMRfl mice. Notably, adipocyte MR deletion increased plasma FGF-21, which was associated with increased FGF-21 and adiponectin protein expression in gWAT. Conversely, MR deletion in HFD-fed female mice did not influence body adiposity, glucose homeostasis, or gWAT gene expression. Conclusions: Deletion of the adipocyte MR activates the FGF-21/β-klotho/adiponectin axis in obese male mice only. Thus, these data indicate that the dysfunctional FGF-21/β-klotho/adiponectin axis is associated with impaired glucose handling in a sex-specific manner.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 562-573 |
| Número de páginas | 12 |
| Publicación | Diabetes, Obesity and Metabolism |
| Volumen | 28 |
| N.º | 1 |
| DOI | |
| Estado | Published - ene 2026 |
Nota bibliográfica
Publisher Copyright:© 2025 John Wiley & Sons Ltd.
Financiación
The authors would like to thank Dr. Pierre Chambon for generously providing the MR floxed mouse line, as well as Dr. Hong Lu for providing technical support for the tamoxifen administration and Mark Ensor for technical support with DNA work. This study was supported by the National Institutes of Health's General Medical Sciences Institute (P20 GM103527), the National Heart, Blood, and Lung Institute (R01 HL135158 to Analia S. Loria), the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (R01DK139147; K01DK128022 to Robert N. Helsley) and the American Heart Association (23CDA1051959 to Robert N. Helsley).
| Financiadores | Número del financiador |
|---|---|
| National Institutes of Health (NIH) | |
| American the American Heart Association | 23CDA1051959 |
| National Institute of Diabetes and Digestive and Kidney Diseases | K01DK128022, R01DK139147 |
| National Heart, Lung, and Blood Institute (NHLBI) | R01 HL135158 |
| National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical Sciences | P20 GM103527 |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Endocrinology
Huella
Profundice en los temas de investigación de 'Adipocyte-specific deletion of the mineralocorticoid receptor improves glucose homeostasis and associates with FGF21-adiponectin signalling in obese male mice'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver